United States Biosimilar Drug Industry Market Analysis & Forecast 2018-2023
In the United States Biosimilar Drug Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9
United States Biosimilar Drug Market: Product Segment Analysis
Injection
Tablets
Others
United States Biosimilar Drug Market: Application Segment Analysis
Trastuzumab
Ankylosing Spondylitis
Others
Reasons for Buying this Report
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9
United States Biosimilar Drug Market: Product Segment Analysis
Injection
Tablets
Others
United States Biosimilar Drug Market: Application Segment Analysis
Trastuzumab
Ankylosing Spondylitis
Others
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
United States Biosimilar Drug Industry Market Analysis & Forecast 2018-2023
CHAPTER 1 BIOSIMILAR DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Market Segmentation by Type
1.2.1 United States Production Market Share of Biosimilar Drug by Type in 2016
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Biosimilar Drug Market Segmentation by Application
1.3.1 Biosimilar Drug Consumption Market Share by Application in 20156
1.3.2 Trastuzumab
1.3.3 Ankylosing Spondylitis
1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biosimilar Drug (2013-2023)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS
3.1 United States Biosimilar Drug Production and Share by Manufacturers (2016 and 2017)
3.2 United States Biosimilar Drug Revenue and Share by Manufacturers (2016 and 2017)
3.3 United States Biosimilar Drug Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilar Drug Market Competitive Situation and Trends
3.5.1 Biosimilar Drug Market Concentration Rate
3.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Biosimilar Drug Production and Market Share by Type (2013-2018)
4.2 United States Biosimilar Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Biosimilar Drug Price by Type (2013-2018)
4.4 United States Biosimilar Drug Production Growth by Type (2013-2018)
CHAPTER 5 UNITED STATES BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION
5.1 United States Biosimilar Drug Consumption and Market Share by Application (2013-2018)
5.2 United States Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES BIOSIMILAR DRUG MANUFACTURERS ANALYSIS
6.1 CP Guojian Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Business Overview
6.2 Biotech Pharma
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Business Overview
6.3 Celgen Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Business Overview
6.4 Henlius
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Business Overview
6.5 company
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Business Overview
6.6 company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.7 company
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Business Overview
6.8 company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.9 company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Business Overview
…
CHAPTER 7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES BIOSIMILAR DRUG MARKET FORECAST (2018-2013)
11.1 United States Biosimilar Drug Production, Revenue Forecast (2018-2013)
11.2 United States Biosimilar Drug Production, Consumption Forecast by Regions (2018-2013)
11.3 United States Biosimilar Drug Production Forecast by Type (2018-2013)
11.4 United States Biosimilar Drug Consumption Forecast by Application (2018-2013)
11.5 Biosimilar Drug Price Forecast (2018-2013)
CHAPTER 12 APPENDIX
CHAPTER 1 BIOSIMILAR DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Market Segmentation by Type
1.2.1 United States Production Market Share of Biosimilar Drug by Type in 2016
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Biosimilar Drug Market Segmentation by Application
1.3.1 Biosimilar Drug Consumption Market Share by Application in 20156
1.3.2 Trastuzumab
1.3.3 Ankylosing Spondylitis
1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biosimilar Drug (2013-2023)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS
3.1 United States Biosimilar Drug Production and Share by Manufacturers (2016 and 2017)
3.2 United States Biosimilar Drug Revenue and Share by Manufacturers (2016 and 2017)
3.3 United States Biosimilar Drug Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilar Drug Market Competitive Situation and Trends
3.5.1 Biosimilar Drug Market Concentration Rate
3.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Biosimilar Drug Production and Market Share by Type (2013-2018)
4.2 United States Biosimilar Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Biosimilar Drug Price by Type (2013-2018)
4.4 United States Biosimilar Drug Production Growth by Type (2013-2018)
CHAPTER 5 UNITED STATES BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION
5.1 United States Biosimilar Drug Consumption and Market Share by Application (2013-2018)
5.2 United States Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES BIOSIMILAR DRUG MANUFACTURERS ANALYSIS
6.1 CP Guojian Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Business Overview
6.2 Biotech Pharma
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Business Overview
6.3 Celgen Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Business Overview
6.4 Henlius
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Business Overview
6.5 company
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Business Overview
6.6 company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.7 company
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Business Overview
6.8 company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.9 company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Business Overview
…
CHAPTER 7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES BIOSIMILAR DRUG MARKET FORECAST (2018-2013)
11.1 United States Biosimilar Drug Production, Revenue Forecast (2018-2013)
11.2 United States Biosimilar Drug Production, Consumption Forecast by Regions (2018-2013)
11.3 United States Biosimilar Drug Production Forecast by Type (2018-2013)
11.4 United States Biosimilar Drug Consumption Forecast by Application (2018-2013)
11.5 Biosimilar Drug Price Forecast (2018-2013)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Type in 2016
Table Application of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Application in 2016
Figure United States Biosimilar Drug Sales and Growth Rate (2013-2023)
Figure United States Biosimilar Drug Revenue and Growth Rate (2013-2023)
Table United States Biosimilar Drug Sales of Key Manufacturers (2016 and 2017)
Table United States Biosimilar Drug Sales Share by Manufacturers (2016 and 2017)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table United States Biosimilar Drug Revenue by Manufacturers (2016 and 2017)
Table United States Biosimilar Drug Revenue Share by Manufacturers (2016 and 2017)
Table 2015 United States Biosimilar Drug Revenue Share by Manufacturers
Table 2016 United States Biosimilar Drug Revenue Share by Manufacturers
Table United States Market Biosimilar Drug Average Price of Key Manufacturers (2016 and 2017)
Figure United States Market Biosimilar Drug Average Price of Key Manufacturers in 2016
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table United States Biosimilar Drug Sales by Type (2013-2018)
Table United States Biosimilar Drug Sales Share by Type (2013-2018)
Figure United States Biosimilar Drug Sales Market Share by Type in 2016
Table United States Biosimilar Drug Revenue and Market Share by Type (2013-2018)
Table United States Biosimilar Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type (2013-2018)
Table United States Biosimilar Drug Price by Type (2013-2018)
Figure United States Biosimilar Drug Sales Growth Rate by Type (2013-2018)
Table United States Biosimilar Drug Sales by Application (2013-2018)
Table United States Biosimilar Drug Sales Market Share by Application (2013-2018)
Figure United States Biosimilar Drug Sales Market Share by Application in 2015
Table United States Biosimilar Drug Sales Growth Rate by Application (2013-2018)
Figure United States Biosimilar Drug Sales Growth Rate by Application (2013-2018)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Market Share (2013-2018)
Table Biotech Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Biotech Pharma Biosimilar Drug Market Share (2013-2018)
Table Celgen Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgen Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgen Pharma Biosimilar Drug Market Share (2013-2018)
Table Henlius Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Henlius Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Henlius Biosimilar Drug Market Share (2013-2018)
Table company 5 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 5 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 5 Biosimilar Drug Market Share (2013-2018)
Table company 6 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 6 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 6 Biosimilar Drug Market Share (2013-2018)
Table company 7 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 7 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 7 Biosimilar Drug Market Share (2013-2018)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 8 Biosimilar Drug Market Share (2013-2018)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 9 Biosimilar Drug Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure United States Biosimilar Drug Production and Growth Rate Forecast (2018-2013)
Figure United States Biosimilar Drug Revenue and Growth Rate Forecast (2018-2013)
Table United States Biosimilar Drug Production Forecast by Type (2018-2013)
Table United States Biosimilar Drug Consumption Forecast by Application (2018-2013)
COMPANIES MENTIONED
CP Guojian Pharma Biotech Pharma Celgen Pharma Henlius
Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Type in 2016
Table Application of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Application in 2016
Figure United States Biosimilar Drug Sales and Growth Rate (2013-2023)
Figure United States Biosimilar Drug Revenue and Growth Rate (2013-2023)
Table United States Biosimilar Drug Sales of Key Manufacturers (2016 and 2017)
Table United States Biosimilar Drug Sales Share by Manufacturers (2016 and 2017)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table United States Biosimilar Drug Revenue by Manufacturers (2016 and 2017)
Table United States Biosimilar Drug Revenue Share by Manufacturers (2016 and 2017)
Table 2015 United States Biosimilar Drug Revenue Share by Manufacturers
Table 2016 United States Biosimilar Drug Revenue Share by Manufacturers
Table United States Market Biosimilar Drug Average Price of Key Manufacturers (2016 and 2017)
Figure United States Market Biosimilar Drug Average Price of Key Manufacturers in 2016
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table United States Biosimilar Drug Sales by Type (2013-2018)
Table United States Biosimilar Drug Sales Share by Type (2013-2018)
Figure United States Biosimilar Drug Sales Market Share by Type in 2016
Table United States Biosimilar Drug Revenue and Market Share by Type (2013-2018)
Table United States Biosimilar Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type (2013-2018)
Table United States Biosimilar Drug Price by Type (2013-2018)
Figure United States Biosimilar Drug Sales Growth Rate by Type (2013-2018)
Table United States Biosimilar Drug Sales by Application (2013-2018)
Table United States Biosimilar Drug Sales Market Share by Application (2013-2018)
Figure United States Biosimilar Drug Sales Market Share by Application in 2015
Table United States Biosimilar Drug Sales Growth Rate by Application (2013-2018)
Figure United States Biosimilar Drug Sales Growth Rate by Application (2013-2018)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Market Share (2013-2018)
Table Biotech Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Biotech Pharma Biosimilar Drug Market Share (2013-2018)
Table Celgen Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgen Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgen Pharma Biosimilar Drug Market Share (2013-2018)
Table Henlius Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Henlius Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Henlius Biosimilar Drug Market Share (2013-2018)
Table company 5 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 5 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 5 Biosimilar Drug Market Share (2013-2018)
Table company 6 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 6 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 6 Biosimilar Drug Market Share (2013-2018)
Table company 7 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 7 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 7 Biosimilar Drug Market Share (2013-2018)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 8 Biosimilar Drug Market Share (2013-2018)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 9 Biosimilar Drug Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure United States Biosimilar Drug Production and Growth Rate Forecast (2018-2013)
Figure United States Biosimilar Drug Revenue and Growth Rate Forecast (2018-2013)
Table United States Biosimilar Drug Production Forecast by Type (2018-2013)
Table United States Biosimilar Drug Consumption Forecast by Application (2018-2013)
COMPANIES MENTIONED
CP Guojian Pharma Biotech Pharma Celgen Pharma Henlius
